Jin Rong Jie·2025-08-04 11:54Group 1 - The core viewpoint of the article highlights that Chunzhi Medical's stock closed at 21.77 yuan, with a 2.40% increase, resulting in a rolling PE ratio of 65.31 times and a total market value of 8.35 billion yuan [1] - The average PE ratio for the medical device industry is 54.32 times, with a median of 38.11 times, placing Chunzhi Medical at the 90th position in the industry ranking [1] - As of March 31, 2025, Chunzhi Medical has 7,167 shareholders, an increase of 501 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Chunzhi Medical specializes in the research, production, and sales of implantable orthopedic medical devices, including spinal, trauma, joint, sports medicine, bone repair materials, surgical instruments, and PRP preparation kits [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 230 million yuan, a year-on-year increase of 3.60%, and a net profit of 58.07 million yuan, a year-on-year increase of 5.20%, with a gross profit margin of 66.69% [1]